Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-24-020469
Filing Date
2024-02-13
Accepted
2024-02-13 17:00:53
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A tv0472-bridgebiopharmainc.htm SC 13G/A 11468
  Complete submission text file 0001104659-24-020469.txt   13143
Mailing Address PO BOX 2600 V26 VALLEY FORGE PA 19482-2600
Business Address PO BOX 2600 V26 VALLEY FORGE PA 19482-2600 6106691000
VANGUARD GROUP INC (Filed by) CIK: 0000102909 (see all company filings)

EIN.: 231945930 | State of Incorp.: PA | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304
Business Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304 (650) 391-9740
BridgeBio Pharma, Inc. (Subject) CIK: 0001743881 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91059 | Film No.: 24627637
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)